The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

Lonza NewsLonza Group AG stock (CH0013841017): pharma supplier in focus after 2025 results and dividend decisi - AD HOC NEWS

10x Genomics NewsThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - AOL.com

FierceBiotechSanofi and Wave post AATD updates in race to end genetic disease’s 40-year new treatment drought

WatersWaters Corporation to Present at the Jefferies Global Healthcare Conference - Yahoo Finance

WatersWaters Corporation to Present at the Jefferies Global Healthcare Conference - Yahoo Finance Australia

Clinical OMICsAI Model Predicts Alzheimer’s Progression from a Single MRI Scan

Clinical OMICsMicrobiome Therapy Could Help Drug-Resistant Melanoma Patients

Clinical OMICsReporter’s Notebook: The Day the Scientific Debate Died

Endpoints NewsAmgen stands by rare disease drug Tavneos amid Japan liver toxicity report

Endpoints NewsFDA's unreleased Covid vaccine deaths report is published by lawmaker

10x Genomics BlogThe 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo! Finance Canada

10x Genomics NewsThe 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo Finance